Analysis Note
ControlBrain tissue
Application
Immunohistochemistry: 1:2,000. Immunostains myelin basic protein of abnormal appearing oligodendrocytic processes and cell bodies in demyelinating areas. The antibody recognizes only areas of myelin degeneration when tested in injured spinal cord and lesioned sciatic nerve. It also stains discrete white matter in brain of multiple system atrophy
Optimal working dilutions must be determined by the end user.
Research Sub CategoryNeuronal & Glial MarkersNeurodegenerative Diseases
Research CategoryNeuroscience
Anti-Myelin Basic Protein Antibody is an antibody against Myelin Basic Protein for use in IH.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Synthetic peptide corresponding to amino acids 69-86 of the guinea pig protein.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Rabbit Serum. Lyophilized, no preservatives. Reconstitute with 50 µL of sterile distilled water. Centrifuge to remove any residue.
Unpurified
Specificity
Recognizes Myelin Basic Protein in demyelinated nerve tissues. Immunohistochemistry analysis of lesioned rat spinal cord shows a high level of specificity for this antiserum.
Storage and Stability
Maintain at -20 to -70°C in undiluted aliquots for up to 12 months after date of receipt. Avoid repeated freeze/thaw cycles. Glycerol (1:1) can be added for additional stability.
This product has met the following criteria to qualify for the following awards: